Columbia’s chief of pediatric critical care and hospital medicine, Hülya Bayır, MD, is researching ways to protect brain tissue and prevent disability or death, after a child suffers a head injury.
Father-daughter team Drs. Natasha and Rudolph Leibel work in parallel at the forefront of science and medicine to improve the treatment of patients with diabetes and obesity.
Columbia’s researchers have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier, enabling higher concentrations of an effective drug to enter the brain.
Columbia researchers are working to determine the prevalence of autoimmune diabetes with a monogenic cause and the factors that can identify those most likely to have it.
Pediatric researchers at Columbia are joining colleagues at 25 institutions across the country to understand more about long COVID and mitigate future impact.
Christopher J. Petit, MD, internationally recognized for clinical innovation and excellence in interventional cardiology, has been appointed Director of Pediatric Cardiology.
Dr. Josh Milner studies rare causes of common diseases such as atopic dermatitis. He uses a step by step diagnostic approach to determine if there is an underlying genetic cause.
Dr. Adolfo Ferrando and his lab members focus primarily on deciphering the mechanisms that lead to chemotherapy resistance and relapse in acute lymphoblastic leukemia.
When Dr. Wendy Chung identified the Olson children's rare disease, “It was like someone turned on the flashlight, and at least now we have a vision of how to move forward," says their mother Colleen.